Submitted:
21 November 2024
Posted:
25 November 2024
You are already at the latest version
Abstract
Keywords:
1. Introduction
2. Materials and Methods
2.1. Clinical Chemistry Analysis Reports
2.2. Prompts and Claude AI chatbot
2.3. Interpretation Accuracy of Claude AI Chatbot
- To ensure standardization of the review process, the medical reviewers used a detailed evaluation rubric that included specific criteria for assessing:
- Accuracy of numerical value interpretation
- Appropriate contextualization of platform-specific reference ranges
- Correct identification of out-of-range values
- Proper handling of unit conversions when necessary
3. Results
3.1.1. Case #1: Diabetic Patient with Critical Glucose Levels (Figure 1)
3.1.2. Case #2a: Iron and Folate Deficiency
3.1.3. Case #2b: Follow-Up Analysis
3.1.4. Case #3: Complex Metabolic Profile (table 4)
3.1.5. Case #4: Complex Metabolic Profile (Figure 2)
4. Discussion
5. Conclusions
Author Contributions
Funding
Data Availability Statement
Institutional review board statement
Informed consent statement
Data availability statement
Acknowledgments
Conflicts of interest
References
- Lee, P.; Bubeck, S.; Petro, J. Benefits, Limits, and Risks of GPT-4 as an AI Chatbot for Medicine. New Engl. J. Med. 2023, 388, 1233–1239. [Google Scholar] [CrossRef] [PubMed]
- Herman, D.S.; Rhoads, D.D.; Schulz, W.L.; Durant, T.J.S. Artificial Intelligence and Mapping a New Direction in Laboratory Medicine: A Review. Clin. Chem. 2021, 67, 1466–1482. [Google Scholar] [CrossRef] [PubMed]
- Naugler, C.; Church, D.L. Automation and artificial intelligence in the clinical laboratory. Crit. Rev. Clin. Lab. Sci. 2019, 56, 98–110. [Google Scholar] [CrossRef] [PubMed]
- Zhang, Z.; Citardi, D.; Xing, A.; Luo, X.; Lu, Y.; He, Z. Patient Challenges and Needs in Comprehending Laboratory Test Results: Mixed Methods Study. J. Med Internet Res. 2020, 22, e18725. [Google Scholar] [CrossRef] [PubMed]
- Yang, H.S.; Wang, F.; Greenblatt, M.B.; Huang, S.X.; Zhang, Y. AI Chatbots in Clinical Laboratory Medicine: Foundations and Trends. Clin. Chem. 2023, 69, 1238–1246. [Google Scholar] [CrossRef] [PubMed]
- Thirunavukarasu, A.J.; Ting, D.S.J.; Elangovan, K.; Gutierrez, L.; Tan, T.F. Large language models in medicine. Nat. Med. 2023, 29, 1930–1940. [Google Scholar] [CrossRef] [PubMed]
- Zhavoronkov, A. Caution with AI-generated content in biomedicine. Nat. Med. 2023, 29, 532–532. [Google Scholar] [CrossRef] [PubMed]
- Steimetz, E.; Minkowitz, J.; Gabutan, E.C.; Ngichabe, J.; Attia, H.; Hershkop, M.; Ozay, F.; Hanna, M.G.; Gupta, R. Use of Artificial Intelligence Chatbots in Interpretation of Pathology Reports. JAMA Netw. Open 2024, 7, e2412767–e2412767. [Google Scholar] [CrossRef] [PubMed]
- Cabitza F, Banfi G. Machine learning in laboratory medicine: waiting for the flood? Clin Chem Lab Med 2018;56:516-24.
- van Dis, E.A.M.; Bollen, J.; Zuidema, W.; van Rooij, R.; Bockting, C.L. ChatGPT: five priorities for research. Nature 2023, 614, 224–226. [Google Scholar] [CrossRef] [PubMed]
- Pennestrì, F.; Banfi, G. Artificial intelligence in laboratory medicine: fundamental ethical issues and normative key-points. cclm 2022, 60, 1867–1874. [Google Scholar] [CrossRef] [PubMed]
- Ali SR, Dobbs TD, Hutchings HA, Whitaker IS. Using ChatGPT to write patient clinic letters. Lancet Digit Health 2023;5:e179-81.
- Ayers, J.W.; Poliak, A.; Dredze, M.; Leas, E.C.; Zhu, Z.; Kelley, J.B.; Faix, D.J.; Goodman, A.M.; Longhurst, C.A.; Hogarth, M.; et al. Comparing Physician and Artificial Intelligence Chatbot Responses to Patient Questions Posted to a Public Social Media Forum. JAMA Intern. Med. 2023, 183, 589–596. [Google Scholar] [CrossRef] [PubMed]
- Carobene A, Cabitza F, Bernardini S, Gopalan R, Lennerz JK, Weir C, et al. Where is laboratory medicine headed in the next decade? Clin Chem Lab Med 2023;61:535-43.
- Zhou, Q.; Qi, S.; Xiao, B.; Li, Q.; Sun, Z.; Li, L. [Artificial intelligence empowers laboratory medicine in Industry 4. 0].. 2020, 40, 287–296. [Google Scholar] [CrossRef]
- Patel SB, Lam K. ChatGPT: the future of discharge summaries? The Lancet Digit Health 2023;5:e107-e108.
- Kung, T.H.; Cheatham, M.; Medenilla, A.; Sillos, C.; De Leon, L.; Elepaño, C.; Madriaga, M.; Aggabao, R.; Diaz-Candido, G.; Maningo, J.; et al. Performance of ChatGPT on USMLE: Potential for AI-assisted medical education using large language models. PLOS Digit. Heal. 2023, 2, e0000198. [Google Scholar] [CrossRef]
- Marks, M.; Haupt, C.E. AI Chatbots, Health Privacy, and Challenges to HIPAA Compliance. JAMA 2023, 330, 309–310. [Google Scholar] [CrossRef]
- Munoz-Zuluaga, C.; Zhao, Z.; Wang, F.; Greenblatt, M.B.; Yang, H.S. Assessing the Accuracy and Clinical Utility of ChatGPT in Laboratory Medicine. Clin. Chem. 2023, 69, 939–940. [Google Scholar] [CrossRef] [PubMed]
- Chen, S.; Kann, B.H.; Foote, M.B.; Aerts, H.J.W.L.; Savova, G.K.; Mak, R.H.; Bitterman, D.S. Use of Artificial Intelligence Chatbots for Cancer Treatment Information. JAMA Oncol. 2023, 9, 1459–1462. [Google Scholar] [CrossRef] [PubMed]


| Case | Sex/Age | Lab report results (out-of range value) |
| #1 | M/65 | RBC: 5.1 mil/μL; HB: 14.0 g/dL; HCT: 42%; MCV: 82 fL; MCH: 28 pg; MCHC: 34 g/dL; WBC: 7.2 mil/μL; Neutrophils: 55%; Lymphocytes: 35%; Monocytes: 7%; Eosinophils: 2%; Basophils: 1%; Glucose: 55 mg/dL; HbA1c: 8.2% ; Total Cholesterol: 270 mg/dL; LDL Cholesterol: 180 mg/dL; Triglycerides: 220 mg/dL; Creatinine: 1.3 mg/dL; Ferritin: 10 ng/mL; GGT: 30 U/L |
| #2(a) | F/35 | AST: 2 U/L; ALT: 9 U/L; GGT: 8 U/L; Serum iron: 27 mch/dL; Ferritin: 29 ng/mL ; Folic Acid: 2,4 ng/mL; Homocysteine: 43 Umol/L; Vit D3: 24 ng/L; Vit B12: 314 pg/ml; HDL Cholesterol: 64 mg/dL; LDL Cholesterol: 37 mg/dL; Total Cholesterol: 114 mg/dL; Triglycerides: 66 mg/dL ; eGFR: 78.58 ml/min/1.73m^2 ; BUN: 43 mg/dL |
| #2(b) | F/35 | RBC: 4.03 mil/μL; HB: 10.2 g/dL; HCT: 32.6%; MCV: 80.9 fL; MCH: 25.3 pg; MCHC: 31.3 g/dL; WBC: 4.5 mil/μL; PLT: 278 10^3/uL; Neutrophils: 55%; Lymphocytes: 37%; Monocytes: 6.3% Eosinophils: 1.1%; Basophils: 0.4%; Serum iron: 27 mch/dL; Ferritin: 26.6 ng/mL; Folic Acid: >20 ng/mL; Homocysteine: 16.2 Umol/L |
| #3 | M/54 | Albumin 56.61%; Alpha 1 3.62%; Alpha 2 9.14%; Beta 1 8.76% ng/ml; Beta 2 5.36%; Gamma 16.5%; A/G Ratio 1.30; Total Proteins 7 g/dl; Ferritin 424 ng/ml; Serum Iron 116 mcg/dl; Gamma GT 29U/dL; ESR 2mm/h; CRP 0.9 mg/dL; AST 19 u/dL; ALT19 u/dL; Total Cholesterol 233 mg/dL; Triglycerides 104 mg/dL; HDL Cholesterol 72 mg/dl; Uric Acid 5.9 mg/ml; Creatinine 1.07 mg/dL; BUN: 24mg/; Glucose: 103 mg/dl; WBC 8.91 x10^3/uL; RBC 5.61 x10^6/uL: Hb 16 g/dL; RBC: 5.6 mil/μL; HCT: 47 %; PLT: 227x10^3/uL; Urine Test: yellow; Ph: 5; Sediment : rare transitional cells |
| #4 | F/50 | WBC: 11.2 x10^9/L; RBC: 4.1 x10^12/L; Hemoglobin: 11.8 g/dL; Hematocrit: 35%; MCV: 85 fL MCH: 28.8 pg; MCHC: 33.7 g/dL; Platelets: 385 x10^9/L; Glucose: 105 mg/dL; BUN: 25 mg/dL; Creatinine: 1.3 mg/dL; eGFR: 58 mL/min/1.73m²; Sodium: 141 mEq/L; Potassium: 3.4 mEq/L; Chloride: 102 mEq/L; CO2: 25 mEq/L |
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content. |
© 2024 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).